A carregar...
MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.
BACKGROUND: Glioblastomas (GBMs) are highly vascular tumors. Therefore, anti-vascular therapy has been regarded as a promising treatment strategy. Yet, recent results from two double-blind, placebo-controlled phase III trials, (RTOG 0825), and (AVAglio), for first-line treatment of GBM patients did...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4144581/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.35 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|